share_log

UPLOAD: Others

UPLOAD: Others

UPLOAD:其他
美股sec公告 ·  05/21 22:15
Moomoo AI 已提取核心訊息
Cingulate Inc., a company listed in the United States, received a communication from the Securities and Exchange Commission (SEC) on May 21, 2024, regarding its Registration Statement on Form S-1, which was filed on May 17, 2024. The SEC informed Cingulate's CEO, Shane Schaffer, that the agency has not reviewed and will not review the registration statement. The SEC's letter referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. Daniel Crawford from the SEC's Division of Corporation Finance, Office of Life Sciences, is the contact person for any further inquiries.
Cingulate Inc., a company listed in the United States, received a communication from the Securities and Exchange Commission (SEC) on May 21, 2024, regarding its Registration Statement on Form S-1, which was filed on May 17, 2024. The SEC informed Cingulate's CEO, Shane Schaffer, that the agency has not reviewed and will not review the registration statement. The SEC's letter referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. Daniel Crawford from the SEC's Division of Corporation Finance, Office of Life Sciences, is the contact person for any further inquiries.
Cingulate公司是一家在美國上市的公司,該公司於2024年5月17日提交了S-1表格的註冊聲明,並於2024年5月21日收到了美國證券交易所(SEC)的文件。SEC告知Cingulate的CEO Shane Schaffer,其機構尚未檢查並且將不會審核該註冊聲明。SEC的信函引用了規則460和461,這些規則涉及對註冊過程的加速請求。此外,SEC提醒該公司及其管理層,無論SEC的審核水平如何,均要確保其披露的準確性和充分性。 SEC的企業融資部生命科學辦公室的Daniel Crawford是進一步查詢的聯繫人。
Cingulate公司是一家在美國上市的公司,該公司於2024年5月17日提交了S-1表格的註冊聲明,並於2024年5月21日收到了美國證券交易所(SEC)的文件。SEC告知Cingulate的CEO Shane Schaffer,其機構尚未檢查並且將不會審核該註冊聲明。SEC的信函引用了規則460和461,這些規則涉及對註冊過程的加速請求。此外,SEC提醒該公司及其管理層,無論SEC的審核水平如何,均要確保其披露的準確性和充分性。 SEC的企業融資部生命科學辦公室的Daniel Crawford是進一步查詢的聯繫人。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息